Aker BioMarine's Lysoveta EPA/DHA formulation is bound by lysophosphatidylcholine to allow the fatty acids to pass through the blood-brain barrier via transporter Mfsd2a.
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
